Global Pharmatech, Inc.Global Pharmatech, Inc.Global Pharmatech, Inc.

Global Pharmatech, Inc.

No trades
See on Supercharts
Market capitalization
‪6.01 M‬USD
−0.0004USD
‪−138.50 K‬USD
‪66.38 K‬USD
‪3.92 M‬
Beta (1Y)
−2.12

About Global Pharmatech, Inc.

CEO
Melson Liao
Headquarters
Hong Kong
Employees (FY)
1
Founded
2001
FIGI
BBG000DZG4H3
Global Pharmatech, Inc. engages in the discovery, development, manufacture, and marketing of proprietary drugs developed based on traditional Chinese medicine. The company was founded on June 26, 2001 and is headquartered in Hong Kong, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GBLP is 0.1500 USD — it has decreased by 37.50% in the past 24 hours. Watch Global Pharmatech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Global Pharmatech, Inc. stocks are traded under the ticker GBLP.
GBLP stock is 60.00% volatile and has beta coefficient of −2.12. Track Global Pharmatech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Global Pharmatech, Inc. there?
Yes, you can track Global Pharmatech, Inc. financials in yearly and quarterly reports right on TradingView.
GBLP net income for the last quarter is ‪−32.28 K‬ USD, while the quarter before that showed ‪−44.48 K‬ USD of net income which accounts for 27.42% change. Track more Global Pharmatech, Inc. financial stats to get the full picture.
No, GBLP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GBLP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Global Pharmatech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GBLP reached its all-time high on May 29, 2002 with the price of 700.0000 USD, and its all-time low was 0.0080 USD and was reached on Nov 12, 2019. View more price dynamics on GBLP chart.
See other stocks reaching their highest and lowest prices.
As of May 5, 2024, the company has 1.00 employees. See our rating of the largest employees — is Global Pharmatech, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Global Pharmatech, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Global Pharmatech, Inc. stock shows the sell signal. See more of Global Pharmatech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Global Pharmatech, Inc. EBITDA is ‪−139.57 K‬ USD, and current EBITDA margin is −210.29%. See more stats in Global Pharmatech, Inc. financial statements.